88 related articles for article (PubMed ID: 15550554)
1. Ameliorating effect of hepatocyte growth factor on inflammatory bowel disease in a murine model.
Oh K; Iimuro Y; Takeuchi M; Kaneda Y; Iwasaki T; Terada N; Matsumoto T; Nakanishi K; Fujimoto J
Am J Physiol Gastrointest Liver Physiol; 2005 Apr; 288(4):G729-35. PubMed ID: 15550554
[TBL] [Abstract][Full Text] [Related]
2. R-spondin1, a novel intestinotrophic mitogen, ameliorates experimental colitis in mice.
Zhao J; de Vera J; Narushima S; Beck EX; Palencia S; Shinkawa P; Kim KA; Liu Y; Levy MD; Berg DJ; Abo A; Funk WD
Gastroenterology; 2007 Apr; 132(4):1331-43. PubMed ID: 17408649
[TBL] [Abstract][Full Text] [Related]
3. Attenuation of mouse acute colitis by naked hepatocyte growth factor gene transfer into the liver.
Hanawa T; Suzuki K; Kawauchi Y; Takamura M; Yoneyama H; Han GD; Kawachi H; Shimizu F; Asakura H; Miyazaki J; Maruyama H; Aoyagi Y
J Gene Med; 2006 May; 8(5):623-35. PubMed ID: 16479533
[TBL] [Abstract][Full Text] [Related]
4. Curcumin prevents and ameliorates trinitrobenzene sulfonic acid-induced colitis in mice.
Sugimoto K; Hanai H; Tozawa K; Aoshi T; Uchijima M; Nagata T; Koide Y
Gastroenterology; 2002 Dec; 123(6):1912-22. PubMed ID: 12454848
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic effects of vasoactive intestinal peptide in the trinitrobenzene sulfonic acid mice model of Crohn's disease.
Abad C; Martinez C; Juarranz MG; Arranz A; Leceta J; Delgado M; Gomariz RP
Gastroenterology; 2003 Apr; 124(4):961-71. PubMed ID: 12671893
[TBL] [Abstract][Full Text] [Related]
6. TWEAK/Fn14 pathway: a nonredundant role in intestinal damage in mice through a TWEAK/intestinal epithelial cell axis.
Dohi T; Borodovsky A; Wu P; Shearstone JR; Kawashima R; Runkel L; Rajman L; Dong X; Scott ML; Michaelson JS; Jakubowski A; Burkly LC
Gastroenterology; 2009 Mar; 136(3):912-23. PubMed ID: 19109961
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic effect of adenoviral-mediated hepatocyte growth factor gene administration on TNBS-induced colitis in mice.
Mukoyama T; Kanbe T; Murai R; Murawaki Y; Shimomura T; Hashiguchi K; Saeki T; Ichiba M; Yoshida Y; Tanabe N; Kurimasa A; Harada K; Yashima K; Hisatome I; Ito H; Murawaki Y; Shiota G
Biochem Biophys Res Commun; 2005 Apr; 329(4):1217-24. PubMed ID: 15766556
[TBL] [Abstract][Full Text] [Related]
8. Repeated enemas with hepatocyte growth factor selectively stimulate epithelial cell proliferation of injured mucosa in rats with experimental colitis.
Setoyama H; Ido A; Numata M; Moriuchi A; Yamaji N; Tamai T; Funakawa K; Fujita H; Sakiyama T; Uto H; Oketani M; Tsubouchi H
Life Sci; 2011 Aug; 89(7-8):269-75. PubMed ID: 21763320
[TBL] [Abstract][Full Text] [Related]
9. Hepatocyte growth factor facilitates colonic mucosal repair in experimental ulcerative colitis in rats.
Tahara Y; Ido A; Yamamoto S; Miyata Y; Uto H; Hori T; Hayashi K; Tsubouchi H
J Pharmacol Exp Ther; 2003 Oct; 307(1):146-51. PubMed ID: 12954797
[TBL] [Abstract][Full Text] [Related]
10. Arsenic trioxide reduces 2,4,6-trinitrobenzene sulfonic acid-induced murine colitis via nuclear factor-κB down-regulation and caspase-3 activation.
Singer M; Trugnan G; Chelbi-Alix MK
Innate Immun; 2011 Aug; 17(4):365-74. PubMed ID: 20693187
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic treatment of experimental colitis with regulatory dendritic cells generated with vasoactive intestinal peptide.
Gonzalez-Rey E; Delgado M
Gastroenterology; 2006 Dec; 131(6):1799-811. PubMed ID: 17087944
[TBL] [Abstract][Full Text] [Related]
12. Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile.
Daniel C; Sartory NA; Zahn N; Radeke HH; Stein JM
J Pharmacol Exp Ther; 2008 Jan; 324(1):23-33. PubMed ID: 17911375
[TBL] [Abstract][Full Text] [Related]
13. A critical role of CD30 ligand/CD30 in controlling inflammatory bowel diseases in mice.
Sun X; Somada S; Shibata K; Muta H; Yamada H; Yoshihara H; Honda K; Nakamura K; Takayanagi R; Tani K; Podack ER; Yoshikai Y
Gastroenterology; 2008 Feb; 134(2):447-58. PubMed ID: 18242212
[TBL] [Abstract][Full Text] [Related]
14. Recombinant human granulocyte colony-stimulating factor reduces colonic epithelial cell apoptosis and ameliorates murine dextran sulfate sodium-induced colitis.
Kudo T; Matsumoto T; Nakamichi I; Yada S; Esaki M; Jo Y; Ohji Y; Yao T; Iida M
Scand J Gastroenterol; 2008; 43(6):689-97. PubMed ID: 18569986
[TBL] [Abstract][Full Text] [Related]
15. Administration of agonistic anti-4-1BB monoclonal antibody leads to the amelioration of inflammatory bowel disease.
Lee J; Lee EN; Kim EY; Park HJ; Chang CY; Jung DY; Choi SY; Lee SK; Lee KW; Kwon GY; Joh JW; Kim SJ
Immunol Lett; 2005 Nov; 101(2):210-6. PubMed ID: 16026855
[TBL] [Abstract][Full Text] [Related]
16. Thalidomide treatment reduces colon injury induced by experimental colitis.
Mazzon E; Muià C; Di Paola R; Genovese T; De Sarro A; Cuzzocrea S
Shock; 2005 Jun; 23(6):556-64. PubMed ID: 15897810
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic action of ghrelin in a mouse model of colitis.
Gonzalez-Rey E; Chorny A; Delgado M
Gastroenterology; 2006 May; 130(6):1707-20. PubMed ID: 16697735
[TBL] [Abstract][Full Text] [Related]
18. Minocycline attenuates experimental colitis in mice by blocking expression of inducible nitric oxide synthase and matrix metalloproteinases.
Huang TY; Chu HC; Lin YL; Lin CK; Hsieh TY; Chang WK; Chao YC; Liao CL
Toxicol Appl Pharmacol; 2009 May; 237(1):69-82. PubMed ID: 19285099
[TBL] [Abstract][Full Text] [Related]
19. Hepatocyte growth factor ameliorates mucosal injuries leading to inhibition of colon cancer development in mice.
Yamaji N; Ido A; Moriuchi A; Numata M; Setoyama H; Tamai T; Funakawa K; Fujita H; Sakiyama T; Uto H; Oketani M; Tsubouchi H
Oncol Rep; 2011 Aug; 26(2):335-41. PubMed ID: 21567095
[TBL] [Abstract][Full Text] [Related]
20. Naked gene therapy of hepatocyte growth factor for dextran sulfate sodium-induced colitis in mice.
Kanbe T; Murai R; Mukoyama T; Murawaki Y; Hashiguchi K; Yoshida Y; Tsuchiya H; Kurimasa A; Harada K; Yashima K; Nishimuki E; Shabana N; Kishimoto Y; Kojyo H; Miura K; Murawaki Y; Kawasaki H; Shiota G
Biochem Biophys Res Commun; 2006 Jul; 345(4):1517-25. PubMed ID: 16735026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
